Results 161 to 170 of about 309,034 (308)

Effect of Language Interpreter Modalities on Patient Satisfaction and Clinical Workflow: A Pilot Study in a Multidisciplinary Pediatric Craniofacial Clinic. [PDF]

Cleft Palate Craniofac J
Juang S, Nguyen S, Osman N, Ghodrati K, Reyes C, Maldonado I, Pino J, Duarte M, Halley K, Hendrickson I, Tu M, Peralta JB, Wilhalme H, Kosack A, Lloyd J, Lerner C, Thang CK.   +16 more
europepmc   +1 more source

Interpreting Interpretative Errors

Zbornik radova Pravnog fakulteta u Splitu
This article examines the attribution of interpretative errors in judicial decision-making, a recurring yet under-theorised element of legal practice. It highlights how ideologies of legal interpretation and legal decision-making shape the criteria for evaluating interpretative correctness and critiques traditional dichotomies between axiological and ...
openaire   +2 more sources

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Assessing the Gaps in Medical Student Usages of Professional Interpreter Services When Caring for Patients With Limited English Proficiency. [PDF]

Cureus
Oladipo A, Wolford C, Sheedy C, Martinez O, Bittman S.   +4 more
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Understanding the telehealth access through an intersectional lens: Experience of Mandarin-speaking consumers accessing health services from a tertiary hospital in Australia. [PDF]

Digit Health
Gallegos-Rejas VM, Kelly JT, Zhang L, Marinucci N, Payne K, Zhou X, Lu Y, Smith AC, Thomas EE.   +8 more
europepmc   +1 more source

Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma

Molecular Oncology, EarlyView.
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff, Manuela Moritz, Dennis Eggert, Anna Worthmann, Joerg Heeren, Henrike Zech, Till S. Clauditz, Waldemar Wilczak, Hartmut Schlüter, Christian S. Betz, Arne Böttcher, Jan Hahn   +11 more
wiley   +1 more source

Building trust and relationship across language barriers: a qualitative study of interpreter-mediated psychotherapy with therapists, interpreters and patients. [PDF]

Int J Equity Health
Topçu MT, Mösko M.
europepmc   +1 more source

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

Molecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala, Sini Ahonen, Sara Peltola, Aura Tuohisto‐Kokko, Olaya Esparta, Peppi Suominen, Anne Jokilammi, Iman Farahani, Deepankar Chakroborty, Nikol Dibus, Steffen Boettcher, Tomi T. Airenne, Mark S. Johnson, Lisa D. Eli, Klaus Elenius, Kari J. Kurppa   +15 more
wiley   +1 more source

Psychological Experiences and Support Needs of Volunteer Psychiatric Interpreters in Japan: A Qualitative Study. [PDF]

Cureus
Zhou Y, Tsutsumi A.
europepmc   +1 more source